Former Stanford President Steps Down From Regeneron Board

Marc Tessier-Lavigne, who resigned as president of Stanford University after questions arose about in his scientific research, is also leaving the board of Regeneron Pharmaceuticals Inc.

Tessier-Lavigne, a neuroscientist who became Stanford’s president in 2016, stepped down from the board of the biopharmaceutical company effective Sept. 1, the company based in Tarrytown, New York, said Friday. He had been a director since 2011.